Comparison Chart Gossamer Bio, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 18/05/2024 am IST			5-day change	1st Jan Change
0.694 ^USD	-4.93%		-6.51%	-23.95%

07/05	Gossamer Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
06/05	Chiesi Farmaceutici S.P.A Gossamer Bio, Inc Announces Transformative Global Collaboration to Develop and Commercialize Seralutinib in Pulmonary Arterial Hypertension and Other Respiratory Indications	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	GOSSAMER BIO, INC.	Other Biotechnology & Medical Research	-4.93%	-6.51%	-23.95%	-51.13%	-96.69%	157M